Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad Halwani, Christopher R. Flowers, Alex F. Herrera et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 20
Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular LymphomaChristopher R. Flowers, Ahmad Halwani, Carlos Panizo et al.|Blood|2018Cited by 7
Intratumoral G100 to induce systemic immune responses and abscopal tumor regression in patients with follicular lymphoma.Christopher R. Flowers, Ahmad Halwani, Iris Isufi et al.|Journal of Clinical Oncology|2017Cited by 2
Feasibility and Clinical Utility of Patient-Reported Outcome Measurement Information System-29 in a Newly Established Adolescent and Young Adult Oncology ProgramPatrick C. Smith, Aniket Saha, Benjamin Snyder et al.|Journal of Adolescent and Young Adult Oncology|2024Cited by 1